Navigation Links
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Date:4/29/2011

EAST BRUNSWICK, N.J., April 29, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it has named Richard Crowley Executive Vice President of Biopharmaceutical Operations, effective April 30, 2011.  Mr. Crowley brings extensive pharmaceutical industry knowledge and experience and will lead the overall management of Savient's manufacturing, regulatory, quality, project management and KRYSTEXXA® product teams.  Mr. Crowley will report directly to Mr. John H. Johnson, Chief Executive Officer of Savient.  

"Rick brings to Savient nearly 25 years of experience in the biotechnology industry along with a proven history of success in leadership roles," said Mr. Johnson.  "His demonstrated ability to achieve strategic corporate goals, combined with his in-depth knowledge of research, development and manufacturing, makes him a tremendous asset to our company as we continue to advance our U.S. launch efforts to bring KRYSTEXXA to patients suffering from refractory chronic gout, as well as pursue opportunities to expand into markets around the world."

Mr. Crowley joins Savient from ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, where he served as Senior Vice President of Biopharmaceutical Operations since 2006.  Prior to that position, he served as Vice President of Manufacturing and General Manager.  Mr. Crowley has also spent significant time at BASF Bioresearch Corporation, Genencor International, Eastman Kodak Company and Monsanto Company.  

Savient Expands KRYSTEXXA Team Following Market Introduction

In addition to Mr. Crowley's appointment, Savient today announced four new functional leaders.  

"We are strategically enhancing our management team to advance KRYSTEXXA's introduction into the market," said Mr. Johnson. "Each of these new members has
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , Germany , and ... , Exclusive global license from ... SF3B1 mutations, including next-generation sequencing (NGS) gene panels, for ... be targeted by new test, indicate favorable prognosis for ... QIAGEN sees potential for developing companion diagnostics ...
(Date:7/24/2014)... COLUMBUS, Ohio, July 24, 2014  Mettler-Toledo International Inc. ... results for 2014.  Provided below are the highlights: ... in the quarter compared with the prior year. Reported ... currency. , Net earnings per diluted share as ... second quarter of 2013. Adjusted EPS was $2.57, an ...
(Date:7/24/2014)... July 24, 2014 Omnicell, Inc. (NASDAQ: ... medication and supply management solutions and analytics software ... July 31, to discuss the Company,s Second Quarter ... Quarter 2014 earnings conference call and webcastWhen: ... Randall Lipps, chairman, president and chief executive officer ...
Breaking Medicine Technology:QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
(Date:7/27/2014)... 2014 According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. , Endoscopy procedures are performed by inserting ...
(Date:7/27/2014)... Prominent Vancouver Chiropractors, Dr. Shervin Ranjbar and ... hamstring release procedure in Vancouver, BC. Both these chiropractors ... and have years of experience in the field of ... by the two professionals using a foam roller exercise. ... release tight hamstrings and relieve the client of the ...
(Date:7/27/2014)... The report, “Oil Filter & Fuel Filter ... Market Type (OE & Aftermarket), Filter Type (Oil & ... Industry Trends & Forecast to 2018”, defines and segments ... analysis and forecasting of the global volume and revenue. ... reach a revenue of $6.1 billion in 2018, while ...
(Date:7/27/2014)... The report provides market analysis ... Market Analysis (Commercial Aviation And Defense Aviation Landing ... - Forecasts 2014 - 2019." The report covers ... shape the market during the study period. It ... that are currently prevailing in the global market. ...
(Date:7/27/2014)... Australia (PRWEB) July 27, 2014 ... in Australia is restricted to two companies, heavy ... to IBISWorld industry analyst Spencer Little, “Demand for ... due to rising health concerns, frequent anti-smoking campaigns, ... result, industry revenue is estimated to fall at ...
Breaking Medicine News(10 mins):Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Renowned Vancouver Chiropractors Demonstrates Hamstring Release in Vancouver, BC 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5Health News:Actuator Systems Market in Aviation Estimated to Reach $3,839.74 Million by 2019 - New Report by MarketsandMarkets 2Health News:Actuator Systems Market in Aviation Estimated to Reach $3,839.74 Million by 2019 - New Report by MarketsandMarkets 3Health News:Actuator Systems Market in Aviation Estimated to Reach $3,839.74 Million by 2019 - New Report by MarketsandMarkets 4Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4
... A ... Medicine, Athletes, Performance, and the Pensacola Fire Department began in April to collect biomechanical data ... ... -- A call comes in to the local Pensacola Fire Department to be first on ...
... and middle-income countries fare the worst, statistics show , THURSDAY, ... death rates, researchers have found that 97 percent of deaths ... in poor and middle-income countries. , While much of the ... of the deaths in this age group occur because of ...
... , TEMECULA, Calif., Sept. 10 Patient Safety ... contract with Partners HealthCare and will be implementing its Safety-Sponge(TM) System ... "Brigham & Women,s has a long tradition of innovation and leadership ... proud of the patient safety research we have done together and ...
... VOORHEES, N.J., Sept. 10 Angioedema is characterized by ... airway, causing discomfort and even death as a result of airway ... and treatment of angioedema, and new therapies are being studied to ... , , To address the need for current ...
... , Calls on Congress to Enact Reform ... Coalition on Liability and Access today commended President Obama for acknowledging ... calls on Congress to follow the President,s leadership by including reform ... night, in an address to Congress, President Obama said, "I,ve talked ...
... , , ... it has established the Edward Neurosciences Institute in affiliation with ... of stroke care in the world to the west and ... http://www.newscom.com/cgi-bin/prnh/20090910/CG73991 ) , , The new Edward ...
Cached Medicine News:Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 2Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 3Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 4Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 5Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 6Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 7Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 8Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 9Health News:Collaborative Research Study Aims to Prevent Firefighter Injury Nationwide 10Health News:Young People at High Risk of Death Worldwide 2Health News:New Directions in Angioedema: A Focus on Supportive Care and Treatment Options 2Health News:Broad Health Coalition Applauds President Obama's Commitment to Medical Liability Reform 2Health News:Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 2Health News:Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 3
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
... CT/GC Controls are liquid controls ... of test procedures that detect ... Since they are specimen specific, ... either urine or endocervical/urethral swabs ...
Liquichek Pediatric Control is a product designed to monitor important analytes for neonatal testing. This control monitors four bilirubin parameters at two clinically significant levels....
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Medicine Products: